Angel News

Angel News

Back to Homepage

15th October 2018

Par Equity invests £1.3m in Censo

Edinburgh-based venture capital firm Par Equity has invested £1.3m in a rapidly growing stem-cell research company that is helping pharmaceutical giants to develop new treatments for diseases including Parkinson’s and Alzheimer’s.


Register now to read full story

In order to read the full story we need you to register with us, please click the link below:

Register Now

Add a comment:




Enter the characters in the image shown:

Back to Homepage